Form Type: 4

SEC EDGAR Link
Accession Number:0001237899-20-000035
Date:2020-07-20
Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
Original Submission Date:

Reporting Person:

FENIMORE CHRISTOPHER R.
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-07-20 M 10,000 a $179.13 25,277 direct
COMMON STOCK 2020-07-20 F 6,291 d $655.57 18,986 direct
COMMON STOCK 2020-07-20 M 2,224 a $52.03 21,210 direct
COMMON STOCK 2020-07-21 S 216 d $636.56 20,994 direct
COMMON STOCK 2020-07-21 S 154 d $637.88 20,840 direct
COMMON STOCK 2020-07-21 S 306 d $638.51 20,534 direct
COMMON STOCK 2020-07-21 S 75 d $639.64 20,459 direct
COMMON STOCK 2020-07-21 S 113 d $640.61 20,346 direct
COMMON STOCK 2020-07-21 S 855 d $641.58 19,491 direct
COMMON STOCK 2020-07-21 S 676 d $642.39 18,815 direct
COMMON STOCK 2020-07-21 S 691 d $643.49 18,124 direct
COMMON STOCK 2020-07-21 S 303 d $644.57 17,821 direct
COMMON STOCK 2020-07-21 S 72 d $645.33 17,749 direct
COMMON STOCK 2020-07-21 S 155 d $646.82 17,594 direct
COMMON STOCK 2020-07-21 S 82 d $647.79 17,512 direct
COMMON STOCK 2020-07-21 S 11 d $658.00 17,501 direct
COMMON STOCK 2020-07-20 0 $0.00 1,432 indirect
COMMON STOCK 2020-07-20 0 $0.00 1,897 indirect f11
COMMON STOCK 2020-07-20 0 $0.00 509 indirect
COMMON STOCK 2020-07-20 0 $0.00 2,284 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
INCENTIVE STOCK OPTION (RIGHT TO BUY) 52.03 2020-07-20 deemed execution date M 2,224 (d) 2021-12-16 common stock 2,224 $52.03 0 direct
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 179.13 2020-07-20 deemed execution date M 10,000 (d) 2022-12-14 common stock 10,000 $179.13 13,500 direct
Footnotes
IDfootnote
f1 disposition/acquisition made pursuant to a plan intended to comply with rule 10b5-1(c).
f2 represents volume-weighted average price of sales of 216 shares of company stock on july 21, 2020 at prices ranging from $636.56 to $636.57. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 21, 2020 at each separate price.
f3 represents volume-weighted average price of sales of 154 shares of company stock on july 21, 2020 at prices ranging from $637.79 to $637.96. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 21, 2020 at each separate price.
f4 represents volume-weighted average price of sales of 306 shares of company stock on july 21, 2020 at prices ranging from $638.44 to $638.73. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 21, 2020 at each separate price.
f5 represents volume-weighted average price of sales of 75 shares of company stock on july 21, 2020 at prices ranging from $639.22 to $639.66. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 21, 2020 at each separate price.
f6 represents volume-weighted average price of sales of 855 shares of company stock on july 21, 2020 at prices ranging from $641.00 to $641.92. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 21, 2020 at each separate price.
f7 represents volume-weighted average price of sales of 676 shares of company stock on july 21, 2020 at prices ranging from $642.25 to $642.93. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 21, 2020 at each separate price.
f8 represents volume-weighted average price of sales of 691 shares of company stock on july 21, 2020 at prices ranging from $643.00 to $643.94. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 21, 2020 at each separate price.
f9 represents volume-weighted average price of sales of 303 shares of company stock on july 21, 2020 at prices ranging from $644.32 to $644.66. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 21, 2020 at each separate price.
f10 represents volume-weighted average price of sales of 155 shares of company stock on july 21, 2020 at prices ranging from $646.71 to $646.92. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 21, 2020 at each separate price.
f11 these shares are held in a trust for the benefit of the reporting person's spouse. the reporting person and the reporting person's spouse are trustees of the trust.
f12 the stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
f13 the stock option award vests in four equal annual installments, commencing one year after the date of grant.
WhaleWisdom Logo

Elevate your investments